Diabetes reduces vascular tetrahydrobiopterin levels by oxidation: Insights from a GTPCH-transgenic mouse model

Documenti analoghi

• Increased endothelial tetrahydrobiopterin levels in GTPCH-transgenic mice
  di: Alp, N, et al.
  Pubblicazione: (2002)
• Increased endothelial tetrahydrobiopterin levels by GTPCH over expression in transgenic mice prevents diabetic endothelial dysfunction
  di: Alp, N, et al.
  Pubblicazione: (2003)
• Reduced levels of tetrahydrobiopterin in diabetic mouse model: Effects on endothelial function and nitric oxide (NO) synthase dimerisation
  di: Cai, S, et al.
  Pubblicazione: (2004)
• Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I over-expression
  di: Alp, N, et al.
  Pubblicazione: (2003)
• Nitric oxide Bioavailability is preserved in diabetes by increased endothelial tetrahydrobiopterin synthesis in targeted GTP cyclohydrolase transgenic mice
  di: Alp, N, et al.
  Pubblicazione: (2003)